AU5805798A - Recombinant adenoviral vector expressing antigens associated with colorectal tumors - Google Patents

Recombinant adenoviral vector expressing antigens associated with colorectal tumors

Info

Publication number
AU5805798A
AU5805798A AU58057/98A AU5805798A AU5805798A AU 5805798 A AU5805798 A AU 5805798A AU 58057/98 A AU58057/98 A AU 58057/98A AU 5805798 A AU5805798 A AU 5805798A AU 5805798 A AU5805798 A AU 5805798A
Authority
AU
Australia
Prior art keywords
adenoviral vector
vector expressing
recombinant adenoviral
antigens associated
colorectal tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58057/98A
Inventor
Dorothee Herlyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Publication of AU5805798A publication Critical patent/AU5805798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU58057/98A 1996-12-31 1997-12-31 Recombinant adenoviral vector expressing antigens associated with colorectal tumors Abandoned AU5805798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77800296A 1996-12-31 1996-12-31
US08778002 1996-12-31
PCT/US1997/023783 WO1998029556A1 (en) 1996-12-31 1997-12-31 Recombinant adenoviral vector expressing antigens associated with colorectal tumors

Publications (1)

Publication Number Publication Date
AU5805798A true AU5805798A (en) 1998-07-31

Family

ID=25111982

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58057/98A Abandoned AU5805798A (en) 1996-12-31 1997-12-31 Recombinant adenoviral vector expressing antigens associated with colorectal tumors

Country Status (2)

Country Link
AU (1) AU5805798A (en)
WO (1) WO1998029556A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7851212B2 (en) 2000-05-10 2010-12-14 Sanofi Pasteur Limited Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
WO2005035773A2 (en) 2003-10-08 2005-04-21 Sanofi Pasteur, Inc. Modified cea /b7 vector
CN1658899B (en) 2002-04-09 2013-01-02 安万特巴斯德有限公司 Modified CEA nucleic acid and expression vectors
WO2005068640A2 (en) * 2003-12-23 2005-07-28 Aventis Pasteur, Inc. Modified ksa and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE248924T1 (en) * 1991-05-06 2003-09-15 Us Gov Health & Human Serv CARCINOEMBRYONAL ANTIGEN-EXPRESSING RECOMBINANT VIRUSES AND METHODS OF THEIR APPLICATION
AU712714B2 (en) * 1994-10-03 1999-11-11 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule B7 gene in a recombinant virus expressing system

Also Published As

Publication number Publication date
WO1998029556A1 (en) 1998-07-09

Similar Documents

Publication Publication Date Title
AU4255397A (en) Chimpanzee adenovirus vectors
IL130899A0 (en) Adenoviruses having altered hexon proteins
AU1116297A (en) Flk-1 binding protein
AU3635899A (en) Recombinant adenovirus gene transfer vector
AU4922497A (en) Interleukin-18-receptor proteins
AU3309997A (en) Recombinant adeno-associated viral vectors
AU2182697A (en) Parapoxvirus vectors
AU5264498A (en) Genes encoding telomerase proteins
AU3381097A (en) Tumor necrosis factor-related polypeptide
AU1655297A (en) Anti-Fas recombinant antibodies and DNA therefor
AU3003095A (en) Proteins associated with tumor necrosis factor receptor
AU3733497A (en) Recombinant sef14 fimbrial protein from salmonella
AU5805798A (en) Recombinant adenoviral vector expressing antigens associated with colorectal tumors
AUPN861496A0 (en) Lytic peptides
AU3640397A (en) Ob protein binding protein
AU1741000A (en) Recombinant factor viii binding peptides
AU5597998A (en) Recombinant plague vaccine
AU6326896A (en) Chemically-modified clostridiatoxin with improved properties
AU1092500A (en) Recombinant e1a deleted adenoviral vectors
AU4586497A (en) Calcium-integrin binding protein
AU2145300A (en) Adenoviral vectors
AU2350997A (en) Novel adenoviral vector for transferring human genes in vivo
AU6844596A (en) Nucleotide sequence encoding the cd33-like protein
AU3036197A (en) Adenovirus vectors for gene therapy
AU4483597A (en) Novel tumor proteins